Immunome, Inc. (IMNM) Reports Q2 Loss of $0.65
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts IMNM Hot Sheet
Join SI Premium – FREE
Immunome, Inc. (NASDAQ: IMNM) reported Q2 EPS of ($0.65), versus ($0.51) reported last year. Revenue for the quarter came in at $0 versus the consensus estimate of $181.82 thousand.
For earnings history and earnings-related data on Immunome, Inc. (IMNM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) PT Raised to $230 at Goldman Sachs ahead of earnings release
- Northrop Grumman wins $66M Navy contract for MQ-4C Triton upgrades
- Broadcom-backed $60bn chip deal hits debt markets - FT
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
